RE: Pharma VC Invests in HEMO at 275% Premium2 Oct 2024 12:16
Prevail Partners, LLC ("Prevail Partners"), an investment fund, has agreed to invest a total of $350,000 (approximately £269,000) in the Company through a subscription for ordinary shares in the Company at a price of US$0.075 per share (approximately 5.6p)
5,6p a lot of catching up to do here, run just started here...imho